China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter real-world study of metabolic regulation combined with progesterone for the care and treatment of obese patients with endometrial cancer and atypical endometrial hyperplasia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129728

Registration Time: 2026/08/09

Type: Observational study

Primary Sponsor: Beijing Obstetrics and Gynecology Hospital, Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=324373

Published by HT Digital Content Services with permission from Health Daily Digest....